{"id":5204,"date":"2026-04-01T17:15:06","date_gmt":"2026-04-01T17:15:06","guid":{"rendered":"http:\/\/www.youtubexyoutube.com\/?p=5204"},"modified":"2026-04-14T19:25:03","modified_gmt":"2026-04-14T19:25:03","slug":"russia-tests-groundbreaking-cancer-treatment","status":"publish","type":"post","link":"http:\/\/www.youtubexyoutube.com\/index.php\/2026\/04\/01\/russia-tests-groundbreaking-cancer-treatment\/","title":{"rendered":"Russia tests groundbreaking cancer treatment"},"content":{"rendered":"

The personalized drug will tackle a patient\u2019s stage three melanoma, with results expected in the coming months<\/strong><\/p>\n

A Russian melanoma patient has received the first personalized cancer vaccine in what is hoped to be a breakthrough in the treatment of the disease, the Russian Health Ministry said in a statement to TASS on Wednesday.<\/p>\n

Last year, the ministry approved two domestically-made medicines: Neooncovac, an mRNA-based vaccine for advanced melanoma, and Oncopept, a peptide treatment targeting aggressive colorectal tumors. Both began human pilot trials in 2025.<\/p>\n

On Tuesday, Neooncovac was administered to its first clinical patient, a 60-year-old male with stage three skin cancer, according to Aleksandr Ginzburg, scientific director of the Gamaleya Research Institute of Epidemiology and Microbiology, which helped develop the breakthrough anti-tumor medicine.<\/p>\n

\u201cSo far, he is doing well; there have been no adverse reactions to the drug,\u201d<\/em> Ginzburg told Russian news portal Gazeta.ru on Wednesday. \u201cHe is 60 years old and has stage three melanoma with metastasis. The vaccine specifically helps fight metastases.\u201d<\/em><\/p>\n

Samples were taken from the patient\u2019s tumor and non-tumor tissue, and researchers analyzed the genome to create a customized vaccine that trains the immune system to attack cancer cells, Ginzburg explained.<\/p>\n

\n Read more<\/strong><\/span><\/p>\n

\n \"Paul
AI helps create cancer vaccine for dying dog<\/a><\/figcaption><\/figure>\n<\/blockquote>\n

According to Andrey Kaprin, head of the National Medical Research Center of Radiology at the Russian Health Ministry, this approach represents a new method of treatment.<\/p>\n

\u201cThis is a fundamentally different approach \u2013 not simply treating the disease, but \u2018training\u2019 the immune system to recognize and destroy precisely those cells that pose a threat,\u201d<\/em> he told TASS on Wednesday.<\/p>\n

The patient will be given 8-9 doses of the medicine at intervals of 2-3 weeks, with his immune response recorded after each injection. Results are expected after three months of treatment.<\/p>\n

\n Read more<\/strong><\/span><\/p>\n

\n \"RT\"
Free personalized cancer vaccines could be rolled out to Russians \u2013 decree<\/a><\/figcaption><\/figure>\n<\/blockquote>\n

Preclinical animal trials had shown tumors disappearing in many cases, with metastases responding in around 90% of tests, Ginzburg has previously said.<\/p>\n

Neooncovac is currently in the final stages of being made available for free treatment under Russia\u2019s national health insurance system, Health Minister Mikhail Murashko told reporters on Wednesday.<\/p>\n

The Gamaleya Center, which made the first registered Covid-19 vaccine, Sputnik V, is also working on medicines targeting other oncological conditions, including pancreatic, kidney and non-small cell lung cancer \u2013 one of the cancers with the highest mortality rate worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"

The personalized drug will tackle a patient\u2019s stage three melanoma, with results expected in the coming months A Russian melanoma […]<\/p>\n","protected":false},"author":1,"featured_media":5206,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[11],"tags":[],"_links":{"self":[{"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/posts\/5204"}],"collection":[{"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/comments?post=5204"}],"version-history":[{"count":2,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/posts\/5204\/revisions"}],"predecessor-version":[{"id":5208,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/posts\/5204\/revisions\/5208"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/media\/5206"}],"wp:attachment":[{"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/media?parent=5204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/categories?post=5204"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.youtubexyoutube.com\/index.php\/wp-json\/wp\/v2\/tags?post=5204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}